CU24274B1 - Compuestos intermediarios para la síntesis de treprostinil - Google Patents

Compuestos intermediarios para la síntesis de treprostinil

Info

Publication number
CU24274B1
CU24274B1 CUP2014000135A CU20140135A CU24274B1 CU 24274 B1 CU24274 B1 CU 24274B1 CU P2014000135 A CUP2014000135 A CU P2014000135A CU 20140135 A CU20140135 A CU 20140135A CU 24274 B1 CU24274 B1 CU 24274B1
Authority
CU
Cuba
Prior art keywords
formula
dichlorobenzyl
intermediates
methyl
space
Prior art date
Application number
CUP2014000135A
Other languages
English (en)
Other versions
CU20140135A7 (es
Inventor
Sanjeevani A Ghone
Nareshkumar F Jain
Michael P Kirkup
Michael A Marella
Original Assignee
Scipharm Sàrl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scipharm Sàrl filed Critical Scipharm Sàrl
Publication of CU20140135A7 publication Critical patent/CU20140135A7/es
Publication of CU24274B1 publication Critical patent/CU24274B1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/56Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
    • C07C47/565Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups all hydroxy groups bound to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P31/00Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/14Benz[f]indenes; Hydrogenated benz[f]indenes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<p>La presente invención se refiere a compuestos intermediarios para producir treprostinil, es un análogo sintético de prostaciclina (PGI2). Dichos compuestos intermediarios tienen la fórmula I o la fórmula II,</p> <p>ESPACIO PARA FÓRMULAS I y II</p> <p>en donde X es Br</p> <p>Y es H</p> <p>PG1 se selecciona entre el grupo que consiste en metilo, metoximetilo, benciloximetilo, metoxietoximetilo, bencilo, 4-metoxibencilo, 2,6-diclorobencilo, 3,4-diclorobencilo; -CH2COOH, -CH2COORx, y –CH2CH2OROPG2;</p> <p>PG2 es THP, SiR1R2R3; O –CH2ORX;</p> <p>R1, R2 y R3 son independientemente uno del otro seleccionado de grupo que consiste de metilo, isopropilo, t-butilo y fenilo;</p> <p>Ra es hidrógeno, hidroxi –ORx, -OCOORx, OSO2Rx, Cl, Br, F, I, - SRx, o –SO2Rx;</p> <p>Rx es Cl-4 alquilo o arilo.</p> <p>También la invención se refiere al compuesto intermediario de la fórmula 17:</p> <p>ESPACIO PARA FÓMULA 17</p>
CUP2014000135A 2012-05-23 2013-05-22 Compuestos intermediarios para la síntesis de treprostinil CU24274B1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261650836P 2012-05-23 2012-05-23
EP12172191.4A EP2674413B1 (en) 2012-06-15 2012-06-15 Process for the preparation of treprostinil and derivatives thereof
PCT/EP2013/060472 WO2013174848A2 (en) 2012-05-23 2013-05-22 Improved process for the preparation of treprostinil and derivatives thereof

Publications (2)

Publication Number Publication Date
CU20140135A7 CU20140135A7 (es) 2015-04-29
CU24274B1 true CU24274B1 (es) 2017-09-06

Family

ID=46262002

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2014000135A CU24274B1 (es) 2012-05-23 2013-05-22 Compuestos intermediarios para la síntesis de treprostinil

Country Status (39)

Country Link
US (1) US9346738B2 (es)
EP (2) EP2674413B1 (es)
JP (1) JP6219376B2 (es)
KR (1) KR102080264B1 (es)
CN (2) CN107963962A (es)
AU (1) AU2013265351B2 (es)
BR (1) BR112014028969B1 (es)
CA (2) CA2873280C (es)
CL (1) CL2014003165A1 (es)
CO (1) CO7240368A2 (es)
CR (1) CR20140534A (es)
CU (1) CU24274B1 (es)
DK (2) DK2674413T3 (es)
DO (1) DOP2014000266A (es)
EA (1) EA027202B1 (es)
EC (1) ECSP14028230A (es)
ES (2) ES2639823T3 (es)
GE (1) GEP201606548B (es)
GT (1) GT201400262A (es)
HR (1) HRP20171340T1 (es)
HU (2) HUE034485T2 (es)
IL (1) IL235734B (es)
LT (1) LT2674413T (es)
MA (1) MA37611B1 (es)
ME (1) ME02861B (es)
MX (1) MX358418B (es)
MY (1) MY174852A (es)
NI (1) NI201400135A (es)
NZ (1) NZ701041A (es)
PE (1) PE20150712A1 (es)
PH (1) PH12014502604A1 (es)
PL (2) PL2674413T3 (es)
PT (2) PT2674413T (es)
RS (1) RS56304B1 (es)
SG (1) SG11201407662WA (es)
SI (1) SI2674413T1 (es)
TN (1) TN2014000486A1 (es)
UA (1) UA118337C2 (es)
WO (1) WO2013174848A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
JP6542128B2 (ja) 2013-01-11 2019-07-10 コルセア ファーマ インコーポレイテッド トレプロスチニルのプロドラッグ
MX2020004912A (es) 2013-10-25 2021-05-21 Insmed Inc Compuestos derivados de prostaciclinas, y el uso de los mismo para el tratamiento de la hipertension pulmonar.
CN111116419B (zh) * 2014-03-04 2022-03-29 江苏豪森药业集团有限公司 曲前列尼尔中间体及其制备工艺
HU231184B1 (hu) 2014-10-08 2021-07-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Treprostinil-nátrium-monohidrát és eljárás ennek előállítására
EP3221291B1 (en) 2014-11-18 2021-03-31 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
TWI540121B (zh) 2014-12-01 2016-07-01 臺灣永光化學工業股份有限公司 曲前列環素二乙醇胺之合成方法及新穎中間體
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
KR101830693B1 (ko) * 2016-04-28 2018-02-21 연성정밀화학(주) 트레프로스티닐의 제조방법 및 이를 위한 중간체
EP3515430A1 (en) 2016-09-26 2019-07-31 United Therapeutics Corporation Treprostinil prodrugs
EP3498283A1 (en) 2017-12-14 2019-06-19 Ipsol AG Glycosidic derivatives of treprostinil
CN108875295A (zh) * 2018-06-21 2018-11-23 华北电力科学研究院有限责任公司 一种利用析因实验设计指导有机物分子修饰改性的方法
KR20220002600A (ko) 2019-04-29 2022-01-06 인스메드 인코포레이티드 트레프로스티닐 전구약물의 건조 분말 조성물 및 이의 사용 방법
JP2022546314A (ja) 2019-08-23 2022-11-04 ユナイテッド セラピューティクス コーポレイション トレプロスチニルプロドラッグ
IL296567A (en) 2020-04-17 2022-11-01 United Therapeutics Corp Terfostinil for use in the treatment of interstitial lung disease
CA3180230A1 (en) 2020-06-09 2021-12-16 Hitesh Batra Fumaryl diketopiperidine prodrugs of treprostinil
US11826328B2 (en) 2020-12-14 2023-11-28 United Therapeutics Corporation Stable treprostinil prodrugs
EP4301372A1 (en) 2021-03-03 2024-01-10 United Therapeutics Corporation A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp)
WO2023154705A1 (en) 2022-02-08 2023-08-17 United Therapeutics Corporation Treprostinil iloprost combination therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242842B1 (en) 1996-12-16 2001-06-05 Siemens Matsushita Components Gmbh & Co. Kg Electrical component, in particular saw component operating with surface acoustic waves, and a method for its production
US6441245B1 (en) * 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6242482B1 (en) * 2000-06-05 2001-06-05 United Therapeutics Corporation Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
US6700025B2 (en) * 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
WO2005007081A2 (en) * 2003-05-22 2005-01-27 United Therapeutics Corporation Compounds and methods for delivery of prostacyclin analogs
WO2011153363A1 (en) * 2010-06-03 2011-12-08 United Therapeutics Corporation Treprostinil production
CA2710726C (en) * 2010-07-22 2016-02-23 Alphora Research Inc. Synthesis of treprostinil and intermediates useful therein

Also Published As

Publication number Publication date
ME02861B (me) 2018-04-20
GT201400262A (es) 2017-11-21
ES2639823T3 (es) 2017-10-30
PT2861554T (pt) 2018-12-27
SG11201407662WA (en) 2014-12-30
BR112014028969A2 (pt) 2020-11-03
MA20150292A1 (fr) 2015-08-31
HUE042516T2 (hu) 2019-06-28
CN104350035A (zh) 2015-02-11
MX2014014237A (es) 2015-05-07
WO2013174848A3 (en) 2014-06-26
CO7240368A2 (es) 2015-04-17
MX358418B (es) 2018-08-20
AU2013265351B2 (en) 2017-03-30
CN107963962A (zh) 2018-04-27
GEP201606548B (en) 2016-09-26
PL2861554T3 (pl) 2019-04-30
WO2013174848A2 (en) 2013-11-28
AU2013265351A1 (en) 2014-11-06
DK2674413T3 (en) 2017-09-18
CL2014003165A1 (es) 2015-03-20
IL235734B (en) 2018-01-31
NZ701041A (en) 2016-08-26
CR20140534A (es) 2015-03-26
CA3118552A1 (en) 2013-11-28
EA201401293A1 (ru) 2015-07-30
CU20140135A7 (es) 2015-04-29
KR20150011350A (ko) 2015-01-30
EP2861554A2 (en) 2015-04-22
HUE034485T2 (en) 2018-02-28
JP2015522545A (ja) 2015-08-06
HRP20171340T1 (hr) 2017-12-15
CA3118552C (en) 2023-10-31
DK2861554T3 (en) 2019-02-18
TN2014000486A1 (en) 2016-03-30
BR112014028969B1 (pt) 2022-01-25
PL2674413T3 (pl) 2018-05-30
PH12014502604A1 (en) 2015-02-02
CN104350035B (zh) 2017-12-12
EP2861554B1 (en) 2018-11-07
US20150126761A1 (en) 2015-05-07
PE20150712A1 (es) 2015-05-20
US9346738B2 (en) 2016-05-24
DOP2014000266A (es) 2015-02-15
PT2674413T (pt) 2017-09-18
KR102080264B1 (ko) 2020-02-21
CA2873280A1 (en) 2013-11-28
EP2674413B1 (en) 2017-06-07
MA37611B1 (fr) 2016-03-31
IL235734A0 (en) 2015-02-01
CA2873280C (en) 2021-07-13
SI2674413T1 (sl) 2017-10-30
MY174852A (en) 2020-05-19
RS56304B1 (sr) 2017-12-29
EP2674413A1 (en) 2013-12-18
NI201400135A (es) 2017-03-13
ES2702347T3 (es) 2019-02-28
LT2674413T (lt) 2017-09-25
ECSP14028230A (es) 2015-09-30
UA118337C2 (uk) 2019-01-10
EA027202B1 (ru) 2017-06-30
JP6219376B2 (ja) 2017-10-25

Similar Documents

Publication Publication Date Title
CU24274B1 (es) Compuestos intermediarios para la síntesis de treprostinil
MX350892B (es) Síntesis de compuesto antiviral.
UY32142A (es) Preparación de una quinoliniloxidifenilciclopropanodicarboxamida
AR087193A1 (es) Compuestos fungicidas 2-[2-cloro-4(4-cloro-fenoxi)-fenil]-1-[1,2,4]triazol-1il-etanol alquilo sustituidos
IN2014CN01136A (es)
RS52872B (en) PIRAL UNITS
UY31367A1 (es) Derivados de nicotinamida, su preparacion y su aplicacion en terapeutica
AR084153A1 (es) Derivados de pirimidinona
IN2014CN04665A (es)
EA201301315A1 (ru) Способ получения промежуточных соединений эстетрола
IN2013MN02014A (es)
BR112022009390A2 (pt) Síntese melhorada de composto inibidor de kras g12c
MX343869B (es) Compuestos, composiciones y artículos fotocromáticos.
NI201000049A (es) Método para producir 2&#39;-desoxi-5-azacitidina (decitabina)
MY159870A (en) Piperazine compound capable of inhibiting prostaglandin d synthase
MX2020005715A (es) Metodos para preparar compuestos de anillos fusionados.
AR105091A1 (es) Procedimiento para la síntesis de derivados de rapamicina
CY1117087T1 (el) Διαδικασια για την παρασκευη εστερων (5-φθορο-2-μεθυλο-3-κινολιν-2-υλμεθυλ-ινδoλ-1-υλ)- οξικου οξεος
HK1155739A1 (en) A benzimidazole derivative as a calcium channel blocker
AR118647A1 (es) Proceso de preparación de 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-deoxi-1-metilamino-d-glucitol
CR20120592A (es) Intermedios de agomelatina y métodos de preparación de estos
UA111950C2 (uk) Гетероциклічні сполуки для лікування або профілактики розладів, викликаних зниженою нейротрансмісією серотоніну, норепінефрину або допаміну
PH12014502108A1 (en) Polyamide compositions with improved optical properties
EA201390170A1 (ru) Составы
UY39789A (es) Intermedio novedoso para la preparación de piroxasulfona.